Trials / Completed
CompletedNCT00541697
Eze/Simva Switch Study in Diabetics (0653A-807)
A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination Tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) Compared to Atorvastatin 20mg in Patients With Type II Diabetes.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 648 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to assess the effectiveness and tolerability of MK0653A and MK0653A versus Atorvastatin in lowering LDL-C levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks | |
| DRUG | Comparator: atorvastatin / Duration of Treatment: 6 Weeks |
Timeline
- Start date
- 2005-01-19
- Primary completion
- 2005-09-28
- Completion
- 2005-10-14
- First posted
- 2007-10-10
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00541697. Inclusion in this directory is not an endorsement.